Global communications and marketing firm Edelman has strengthened its health public affairs capabilities with the addition of Alan Maine, who joins as its senior director.
Maine, who previously served as head of policy and public affairs at Pfizer UK, was responsible for government affairs and market access policy development activity, covering both corporate and therapy area public affairs.
During his time at Pfizer, Maine also worked with industry associations on campaigns, policies and initiatives relating to access to medicines.
He said: “I am delighted to be working with such a forward-looking company as Edelman and I am thrilled to work with the team to deliver innovative and strategic campaigns.”
Prior to his time with Pfizer, Maine was head of government affairs at Wyeth Pharmaceuticals – later acquired by Pfizer – and has held other roles with Merck Sharpe & Dohme.
Kate Hawker, managing director for Edelman UK, said: “We are very excited about Alan joining Edelman as he brings with him such great knowledge and insight of the complex challenges in the UK.”